Production (Stage)
Artelo Biosciences, Inc.
ARTL
$1.00
$0.033.09%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -90.20% | -77.58% | -62.24% | -59.96% | -50.86% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -63.39% | -60.47% | -77.13% | -7.36% | -35.88% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -83.12% | -76.71% | -62.87% | -57.76% | -50.03% |
|
|
|||||
| Total Current Assets | -83.12% | -76.71% | -62.87% | -57.76% | -50.03% |
| Net Property, Plant & Equipment | -26.61% | 371.43% | 272.41% | 197.44% | 148.00% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | -98.48% | 0.00% |
| Total Assets | -66.05% | -63.98% | -53.96% | -50.67% | -43.97% |
|
|
|||||
| Total Accounts Payable | 313.34% | 35.62% | -25.36% | 65.01% | -13.41% |
| Total Accrued Expenses | -72.29% | 103.33% | -14.29% | -4.35% | -4.60% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 16.13% | 52.17% | 6.25% | -2.94% | -16.22% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 288.90% | 37.26% | -24.32% | 55.89% | -12.61% |
|
|
|||||
| Total Current Liabilities | 288.90% | 37.26% | -24.32% | 55.89% | -12.61% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -38.54% | -- | -- | 1,350.00% | 540.00% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 250.43% | 42.60% | -15.85% | 68.64% | -2.74% |
|
|
|||||
| Common Stock & APIC | 1.63% | 1.78% | 1.77% | 2.87% | 2.94% |
| Retained Earnings | -22.70% | -24.38% | -24.49% | -30.00% | -28.94% |
| Treasury Stock & Other | -11.82% | 0.49% | -9.55% | -1.00% | 0.98% |
| Total Common Equity | -93.16% | -75.69% | -56.37% | -55.13% | -45.93% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -93.16% | -75.69% | -56.37% | -55.13% | -45.93% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -93.16% | -75.69% | -56.37% | -55.13% | -45.93% |
|
|
|||||